logo

Video encyclopedia

Samuel D. Waksal

Biography

1:55

Sentence in insider trading scandal

 

3:53

Immunologist Sam Waksal explains the importance of everyone taking the Covid-19 vaccine

 

0:54

Sam Waksal May Buy Three Rivers; Creditors Can Sue Zell: Video

 

2:08

Nightly Business Report: Sam Waksal is returning to Wall Street

 

0:23

Sam Waksal

Samuel D. "Sam" Waksal is the founder and former CEO of the biopharmaceutical company ImClone Systems. He is also the founder of Kadmon Pharmaceuticals which was financed with private capital and commenced operations in New York City in 2010. At ImClone, Waksal led the company to develop the cancer drug Erbitux (cetuximab). During the course of its review process with Food and Drug Administration (FDA) Waksal became involved in an insider trading scandal revolving around improper communications with personal friends and family members. He was convicted of several securities violations, served time in federal prison, and was released.
    • Personal 

    • ImClone Systems 

    • Criminal activity and conviction 

    • Kadmon Pharmaceuticals